Researchers have been excited about the medication , a innovative dual treatment showing significant outcomes in early trials for body reduction . It functions by impacting several pathways : GLP-1 and GIP, that , when activated , assist regulate cravings and boost calorie burn. Preliminary observations suggest noteworthy size reduction and possibl